Heterologous COVID Booster: No Better Response in Kidney Patients

Kidney transplant recipients have similar outcomes with both heterologous and homologous third SARS-Cov-2 vaccine doses, a randomized clinical trial suggests.
Reuters Health Information

source https://www.medscape.com/viewarticle/965692?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension